Q1 2025 Holdings
Filed 2025-05-15 | 84 holdings | $128.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $25.1M | 977,245 | 19.6% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $7.8M | 9,416 | 6.1% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $6.8M | 12,895 | 5.3% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $5.9M | 370,513 | 4.6% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $5.6M | 800,787 | 4.4% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $3.6M | 21,800 | 2.8% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $3.6M | 32,020 | 2.8% |
| Amgen Inc(AMGN) | COM | 031162100 | $3.2M | 10,385 | 2.5% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $3.1M | 14,800 | 2.4% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $2.6M | 5,250 | 2.0% |
| Abbott Labs(ABT) | COM | 002824100 | $2.5M | 18,698 | 1.9% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $2.4M | 24,226 | 1.9% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $2.4M | 26,900 | 1.9% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $2.3M | 4,725 | 1.8% |
| Stryker Corp(SYK) | COM | 863667101 | $2.3M | 6,100 | 1.8% |
| Danaher Corporation(DHR) | COM | 235851102 | $2.2M | 10,575 | 1.7% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $2.1M | 23,850 | 1.7% |
| Argenx SE(ARGX) | SP ADR | 04016X101 | $1.8M | 3,103 | 1.4% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $1.8M | 2,773 | 1.4% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $1.7M | 23,530 | 1.3% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $1.6M | 3,250 | 1.3% |
| Biontech SE(BNTX) | SP ADR | 09075V102 | $1.6M | 17,175 | 1.2% |
| Pfizer Inc(PFE) | COM | 717081103 | $1.5M | 59,650 | 1.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $1.4M | 5,205 | 1.1% |
| Astrazeneca PLC(AZN) | SP ADR | 046353108 | $1.4M | 18,790 | 1.1% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $1.3M | 69,240 | 1.0% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $1.3M | 100,205 | 1.0% |
| Legend Biotech Corp(LEGN) | SP ADR | 52490G102 | $1.2M | 35,965 | 0.9% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $1.2M | 9,000 | 0.9% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $1.2M | 19,500 | 0.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.2M | 15,230 | 0.9% |
| Springworks Therapeutics Inc | COM | 85205L107 | $1.1M | 25,325 | 0.9% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $1.1M | 29,920 | 0.8% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $1.0M | 678,574 | 0.8% |
| Dexcom Inc(DXCM) | COM | 252131107 | $1.0M | 15,000 | 0.8% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $994.4K | 11,235 | 0.8% |
| Radnet Inc(RDNT) | COM | 750491102 | $994.4K | 20,000 | 0.8% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $886.1K | 17,250 | 0.7% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $877.9K | 107,585 | 0.7% |
| Phreesia Inc(PHR) | COM | 71944F106 | $869.0K | 34,000 | 0.7% |
| Cvrx Inc(CVRX) | COM | 126638105 | $837.8K | 68,500 | 0.7% |
| Beigene LTD(ONC) | SP ADR | 07725L102 | $796.6K | 2,927 | 0.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $794.5K | 21,040 | 0.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $726.2K | 18,068 | 0.6% |
| Icon PLC(ICLR) | SHS | G4705A100 | $700.0K | 4,000 | 0.5% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $680.9K | 28,348 | 0.5% |
| Clover Health Investments Co(CLOV) | COM CL A | 18914F103 | $657.0K | 183,000 | 0.5% |
| Elevance Health Inc(ELV) | COM | 036752103 | $652.4K | 1,500 | 0.5% |
| Uniqure NV(QURE) | SHS | N90064101 | $610.0K | 57,550 | 0.5% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $590.3K | 15,108 | 0.5% |